Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%) Natco Pharma - Quaterly Results
Date: 10-11-2022
The September 2022 quarter revenue stood at Rs. 3511.00 millions, up 6.27% as compared to Rs. 3304.00 millions during the corresponding quarter last year.A slender decline of -29.66% was recorded to Rs. 377.00 millions from Rs. 536.00 millions in the corresponding previous quarter.A decline of 863.00 millions was observed in the OP in the quarter ended September 2022 from 897.00 millions on QoQ basis.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202209 | 202109 | % Var | 202209 | 202109 | % Var | 202203 | 202103 | % Var | |
| Sales | 3511.00 | 3304.00 | 6.27 | 11568.00 | 7242.00 | 59.73 | 17678.00 | 16535.00 | 6.91 |
| Other Income | 162.00 | 403.00 | -59.80 | 494.00 | 526.00 | -6.08 | 946.00 | 1011.00 | -6.43 |
| PBIDT | 863.00 | 897.00 | -3.79 | 4989.00 | 2156.00 | 131.40 | 3076.00 | 5187.00 | -40.70 |
| Interest | 17.00 | 32.00 | -46.88 | 44.00 | 50.00 | -12.00 | 133.00 | 113.00 | 17.70 |
| PBDT | 846.00 | 865.00 | -2.20 | 4945.00 | 2106.00 | 134.81 | 2943.00 | 5074.00 | -42.00 |
| Depreciation | 383.00 | 342.00 | 11.99 | 752.00 | 673.00 | 11.74 | 1384.00 | 1152.00 | 20.14 |
| PBT | 463.00 | 523.00 | -11.47 | 4193.00 | 1433.00 | 192.60 | 1559.00 | 3922.00 | -60.25 |
| TAX | 86.00 | -13.00 | -761.54 | 736.00 | 145.00 | 407.59 | 168.00 | 827.00 | -79.69 |
| Deferred Tax | -6.00 | -113.00 | -94.69 | -16.00 | -110.00 | -85.45 | -157.00 | -106.00 | 48.11 |
| PAT | 377.00 | 536.00 | -29.66 | 3457.00 | 1288.00 | 168.40 | 1391.00 | 3095.00 | -55.06 |
| Equity | 365.00 | 365.00 | 0.00 | 365.00 | 365.00 | 0.00 | 365.00 | 365.00 | 0.00 |
| PBIDTM(%) | 24.58 | 27.15 | -9.46 | 43.13 | 29.77 | 44.87 | 17.40 | 31.37 | -44.53 |